lucky 7 casino game

lucky 7 casino game Moore scores 20 as Norfolk State beats Grambling 76-70

Republicans lash out at Democrats' claims that Trump intelligence pick Gabbard is 'compromised'

UNCASVILLE, Conn. (AP) — Brian Moore Jr. scored 20 points to help Norfolk State defeat Grambling 76-70 on Friday night. Moore had 10 rebounds for the Spartans (8-6). Christian Ings finished 6 of 6 from the field to add 13 points. Kuluel Mading finished 4 of 8 from the field to finish with 10 points. Ernest Ross and Louis Hutchinson each scored 15 points for the Tigers (2-9). Kintavious Dozier had 14 points. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

Sources: Yanks get Fried for $218M, record for LHPTrump's cabinet: Who's been picked, who's in the running?

McDaniels 4-13 0-0 10, Randle 7-15 8-13 23, Gobert 4-5 2-2 10, A.Edwards 9-21 4-4 28, DiVincenzo 4-8 0-0 11, Minott 0-0 0-0 0, Reid 2-9 0-0 5, Alexander-Walker 1-7 2-2 4, Dillingham 6-10 0-0 14. Totals 37-88 16-21 105. Brown 10-18 2-2 29, Tatum 8-21 5-6 26, Horford 3-10 0-0 8, Holiday 3-10 2-2 9, White 7-12 1-2 19, Hauser 2-7 0-0 5, Tillman 1-2 1-2 3, Pritchard 3-7 1-1 8. Totals 37-87 12-15 107. 3-Point Goals_Minnesota 15-41 (A.Edwards 6-11, DiVincenzo 3-6, Dillingham 2-4, McDaniels 2-6, Randle 1-4, Reid 1-6, Alexander-Walker 0-4), Boston 21-56 (Brown 7-10, Tatum 5-12, White 4-9, Horford 2-9, Hauser 1-5, Pritchard 1-5, Holiday 1-6). Fouled Out_None. Rebounds_Minnesota 49 (Gobert 20), Boston 40 (White 9). Assists_Minnesota 19 (A.Edwards 7), Boston 25 (White 5). Total Fouls_Minnesota 18, Boston 23. A_19,156 (18,624)Canada thumped Trinidad and Tobago 38-0 to win the Rugby Americas North (RAN) Sevens on Sunday and qualify for World Rugby’s second-tier Challenger Series. The tournament-favourite Canadian men outscored their opposition 169-0 over five matches in a first step back up the rugby sevens ladder since being relegated from the elite HSBC SVNS circuit in June. The top four teams from the three-event Challenger Series will face off against the bottom four from the HSBC SVNS at the SVNS World Championships May 3-4 in Carson, Calif., in a promotion/relegation playoff. “I think it’s just about continually building,” said Canada captain Elias Hancock. “We know what we’re capable of. We’ve shown it at times. It’s just time to get back to that place where we know we belong.” Prior to relegation, Canada had been a core team on the top sevens circuit since 2012-13 and lifted the trophy in Singapore in 2017. The Canadian men finished eighth at the Tokyo Olympics. Trinidad had plenty of the ball in the first half of Sunday’s final at Larry Gomes Stadium. But Canada, helped by several penalties, scored first with Hancock touching down under the posts for a try converted by Thomas Isherwood. Matt Oworu, beating two defenders, added another converted try for a 14-0 lead at the break. Cooper Coats added a converted try early in the second half. And Hancock, Jack Shaw and Noah Bain added late tries after Trinidad lost a man to the sin-bin for two minutes midway through the second half for an infraction off a Canadian kickoff. Earlier Sunday, the Canadians defeated Jamaica 26-0 in semifinal play and the Cayman Islands 38-0 in the quarterfinal. Trinidad and Tobago made it to the final — for the first time since 2013 — with a 19-7 comeback win over Mexico. Jamaica defeated Mexico 12-0 to finish third. Weather was a factor during the three-day tournament in Arima, some 30 kilometres east of Port of Spain. After enduring 30-plus C heat and humidity Friday, their final Pool A game against Barbados was abandoned Saturday due to a storm. On Sunday, the Canadians played the Cayman Islands in a downpour and the skies opened again at halftime of the Jamaica game. Alex Russell, Josiah Morra, Coats and Hancock scored tries against Jamaica for Canada, which led 12-0 at the break. Thomas Isherwood added three conversions. Morra and Hancock each scored two tries against the Caymans and Ethan Hager and D’Shawn Bowen added singles for Canada, which led 19-0 at the half. Canada added four conversions. Canada, which blanked Guyana 29-0 Friday, dispatched Bermuda 38-0 Saturday and was leading Barbados 10-0 when the game was halted in the first half due to heavy rain and high winds. While play eventually resumed, the interrupted Canada game was ruled a scoreless draw. The Canadian men are coming off a disastrous 3-36-0 HSBC SVNS season that ended with a 22-14 loss to Spain with relegation on the line. It was a 29th straight defeat. After being relegated, coach Sean White’s team fell short in an Olympic repechage tournament in late June in Monaco, finishing fourth after losing 26-0 to eventual winner South Africa in the semifinals. The Blitzboks went on to claim bronze in Paris. The 13-man roster for the RAN 7s includes six players who were part of the relegation playoff in Madrid: Hancock, Isherwood, Morra, Coats, Oworu and David Richard. Morra, Coats and Oworu joined the sevens team from Bucharest where they were part of Kingsley Jones’ Canadian 15s squad for test matches against Chile and Romania. The Canadian men are scheduled to play in an invitational men’s sevens tournament taking place at B.C. Place Stadium alongside the HSBC SVNS Vancouver stop in February. The Canadian women left Sunday for Dubai and the opening stop of the 2005 HSBC SVNS season. The Olympic silver-medallist Canadians open play next Saturday against Japan before facing Brazil and Olympic champion New Zealand.These holiday gifts change the game when building fires, printing photos, watching birds and more

Cybersecurity for regional Australians: Protecting your digital presenceLandstar Announces Special Dividend

Why you're wrong about AI art, according to the Ai-Da robot that just made a $1 million painting

15,830 Shares in Hancock Whitney Co. (NASDAQ:HWC) Acquired by B. Metzler seel. Sohn & Co. Holding AG

THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE AmgenFlorida State continues torrid star with rout of UMass

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it has drawn down the final tranche of €5 million (“Tranche C”) under the credit facility agreement for up to €40 million entered into with the European Investment Bank (the “EIB) on December 28, 2022 (the "Finance Contract"). With the drawdown of Tranche C, the Company has drawn down the full €40 million available under the Finance Contract. Tranche C is expected to be disbursed by the EIB by December 18, 2024. The Company plans to use the proceeds of Tranche C towards the development of its pipeline of allogeneic CAR T-cell product candidates: UCART22 and UCART20x22. As a condition to the disbursement of Tranche C the Company issued 611,426 warrants to the benefit of the EIB, in accordance with the terms of the 14 th resolution of the shareholders’ meeting held on June 28, 2024 and articles L. 228-91 and seq. of the French Commercial Code (the “Tranche C Warrants”). Each Tranche C Warrant allows the EIB to subscribe for one ordinary share of the Company, at a price of €1.70, corresponding to 99% of the volume-weighted average price of the Company’s ordinary shares over the last 3 trading days preceding the decision of the board of directors of the Company to issue the Tranche C Warrants. The total number of shares issuable upon exercise of the Tranche C Warrants represent circa 0.6% of the Company’s outstanding share capital as at their issuance date. Tranche C will mature six years from its disbursement date and will accrue interest at a rate of 6% per annum capitalized annually and payable at maturity. The other terms of the Tranche C Warrants and prepayment events of Tranche C under the Finance Contract are as set forth in the Company’s press release of April 4, 2023 and Form 6-K filed with the U.S. Securities and Exchange Commission on such date. About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. Cellectis utilizes an allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to make therapeutic gene editing in hemopoietic stem cells for various diseases. As a clinical-stage biopharmaceutical company with 25 years of experience and expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN ® , its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to treat diseases with unmet medical needs. Cellectis’ headquarters are in Paris, France, with locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit our website: www.cellectis.com Follow Cellectis on social networks @cellectis on LinkedIn and X (formerly Twitter) TALEN® is a registered trademark owned by Cellectis. Cautionary Statement This press release contains “forward-looking” statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as “expect,” “plan,” and “will,” or the negative of these and similar expressions. These forward-looking statements, which are based on our management’s current expectations and assumptions and on information currently available to management. Forward-looking statements include statements about the date of disbursement of the Tranche C and the use of the proceeds of amounts received under the Finance Contract. These forward-looking statements are made in light of information currently available to us and are subject to numerous risks and uncertainties, including with respect to the numerous risks associated with market conditions, and our ability to satisfy the conditions precedent under the Finance Contract. Furthermore, many other important factors, including those described in our Annual Report on Form 20-F as amended and in our annual financial report (including the management report) for the year ended December 31, 2023 and subsequent filings Cellectis makes with the Securities Exchange Commission from time to time, which are available on the SEC’s website at www.sec.gov , as well as other known and unknown risks and uncertainties may adversely affect such forward-looking statements and cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Interim Chief Financial Officer, investors@cellectis.com Attachment 20241128_Cellectis_BEI_Tranche C_ENGLISH_PR-MBTNEW YORK - Wall Street’s main indexes closed lower on Dec 10 as investors anxiously awaited key inflation reports that could influence the Federal Reserve’s interest rate decision next week. Among the S&P 500‘s 11 major industry sectors, communication services was the biggest boost with help from a rally in shares of Google-parent Alphabet after it unveiled a new chip. The biggest drag was from technology, pressured by a sell-off in Oracle shares after the cloud computing company missed Wall Street estimates for second-quarter results. Also weighing on technology was a sell-off in chips after China announced on Dec 9 an investigation into Nvidia over suspected violations of the country’s anti-monopoly law. The probe was widely seen as retaliation against Washington’s latest curbs on the Chinese chip sector. According to preliminary data, the S&P 500 lost 16.53 points, or 0.27 per cent, to end at 6,036.32 points, while the Nasdaq Composite lost 49.45 points, or 0.25 per cent, to 19,687.24. The Dow Jones Industrial Average fell 143.46 points, or 0.32 per cent, to 44,259.60. A November reading of the Consumer Price Index, due on Dec 11, is among the last major reports ahead of the Fed’s Dec 17-18 meeting. Headline inflation is expected to have risen slightly in November to 2.7 per cent from 2.6 per cent in October. The Producer Price Index report will follow on Dec 12. “There’s a little bit of wait-and-see in the market ahead of the CPI and PPI data this week,” said Ms Mona Mahajan, head of investment strategy at Edward Jones. “Markets want to see a number that won’t be too disruptive to the Fed next week.” If the CPI comes in line with estimates, investors will expect an “all clear” for the Fed to lower rates by 25 basis points next week, she added. Traders see an 86 per cent chance for a cut next week, CME’s FedWatch Tool showed. Bets had jumped after news on Dec 6 of an uptick in unemployment along with a rebound in job growth, which had slowed in October. Noting the S&P 500‘s roughly 27 per cent gain for the year so far, Ms Lindsey Bell, chief strategist at 248 Ventures in Charlotte, North Carolina, said investors are cautious ahead of the economic data and Fed meeting. “We’re in a seasonally strong period of the year and investors are just kind of taking a breather,” said Ms Bell. Market participants will be watching out for signs that the US central bank will pause its easing cycle in January, after a host of Fed officials last week hinted at a slower pace of monetary policy easing on the back of a resilient economy. “It’s less about what the Fed does next week but what they say about the future trajectory of interest rates,” said Ms Bell. Among individual stock movers, software firm MongoDB lost ground despite raising its forecast for annual results. Shares in Walgreens Boots Alliance rallied after reports that it is in talks to sell itself to private equity firm Sycamore Partners. Alaska Airlines shares rose as it raised its fourth-quarter profit forecast, while Boeing gained ground after Reuters reported the planemaker restarted production of its 737 Max jets last week. Luxury homebuilder Toll Brothers shares fell after its quarterly results beat expectations but its current quarter forecasts disappointed. REUTERS

The 26th edition of Shaastra, hosted by the Indian Institute of Technology-Madras, will be held from January 3 to 7, 2025. The Hindu is the media partner for IIT Shaastra Themed on “Fractal Frontiers,” Shaastra 2025 draws inspiration from the intricate shapes and patterns found in nature. Preparations are underway and over 60,000 people are expected to participate in India’s largest student-run techno-entertainment festival. Sathyanarayana N. Gummadi, Dean (Students), IIT Madras, said, “This year, we are introducing two new areas in the Shaastra Summit and Research Conference: ‘Future Cities’ and ‘Smart Manufacturing’. We are looking forward to the contributions from all the stakeholders towards sustainable approaches in these domains.” Over 110 events With over 110 events ranging from dynamic hackathons and biotechnology challenges to exciting workshops by industry experts, the festival serves as a premier hub for intellectual engagement. Co-Curricular Adviser Murugaiyan Amirthalingam said, “Shaastra serves as a dynamic platform for learning and innovation, bringing together over 50 workshops on several topics. It offers students and tech enthusiasts a unique chance to gain invaluable hands-on experience in cutting-edge domains.” Shaastra’s flagship Spotlight lecture series, presented by Shaastra’s title sponsor the National Institute of Ocean Technology (NIOT), features 10 eminent speakers, including Arokiaswamy Velumani, Founder-CEO, Thyrocare Technologies; Ruchira Kamboj, former Permanent Representative of India to the United Nations; and Dr. Subir Sachdev, Herchel Smith Professor of Physics at Harvard University. This year’s event lineup features Caterpillar Autonomy Challenge, presented by Caterpillar Inc., which showcases the autonomous capabilities and precision picking skills of robots designed for space exploration. The FedEx SMART Centre, an IIT-M body, will host the pilot edition of its flagship hackathon to recruit students for a summer internship. Comedy Night Speaking about the entertainment at Shaastra, Vaishnavi, who leads the Shows & Exhibitions vertical of Shaastra, said, “For the first time ever, we’re hosting a Comedy Night with the incredible Gurleen Pannu on January 6, 2025.” Other highlights include the electrifying RoboWars on January 4 sponsored by IDFC FIRST Bank and Bajaj Auto, the Techno-Entertainment Night on January 5, featuring headliners Karan Kanchan and international artist Camilla Lynx, and Jarvis Lab’s tech-entertainment production Envisage 13.0 on January 3. Co-curricular Affairs Secretary Sukheth Kallupalli shared, “Shaastra 2025 will be a testament to IIT Madras’s commitment to sustainability and environmental stewardship. By replacing all plastic and vinyl banners with reusable cloth-based branding and implementing measures to drastically cut our carbon footprint, we are proud to align with the UN SDGs and India’s mission to achieve net zero by 2070.” Adding to its intellectual appeal, Shaastra’s International Research Conference, sponsored by Temenos, will host 160+ dignitaries exploring groundbreaking ideas on Industry 4.0, culminating in a one-of-its-kind publication. Meanwhile, L&T’s International Summit on Future Cities will bring together professionals and students to envision the future of urban landscapes, fostering innovative and sustainable solutions. Boeing is set to host its iconic national aeromodeling contest in association with IIT Madras across four different IITs. Focus on farmers This year’s campaign, “Uzhavu,” focuses on empowering Indian farmers through AI and technology, aiming to bolster the agrarian economy. In addition to upskilling sessions for farmers, awareness programmes have been held in schools and colleges, while a national hackathon has been launched among others. Sukheth said of the social campaign, “Through initiatives like tech-enabled soil testing and precision farming in Chengalpattu, we aim to provide hundreds of farmers with crop cycle recommendations based on geolocation data, weather patterns, and economic feasibility in a six-month project. Uzhavu also seeks to create and distribute pollinator pods to support the declining bee population. The support of firms such as National Agro Foundation, Tamil Nadu Climate Change Mission and School of Sustainability, IIT Madras, has been instrumental in making this vision a reality.” Through initiatives like Macmillan’s Budding Scientists Programme and the Junior Make-a-thon, school students will also be a part of the festivities. This edition of Shaastra also introduces Rewire, a cognitive enhancement initiative to promote multisensory learning and neuroscience-backed teaching methodologies. Rewire hosted a national toy-designing competition sponsored by the organisation Help Them Shine, and will organise a national teachers’ conference on January 4 and 5, 2025 during the festival to develop action plans for inclusive pedagogies, particularly for neurodiverse students. Tickets for Shaastra are available on the Shaastra website. To register for the event, scan the QR code. · Published - December 26, 2024 11:07 pm IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit education / Chennai

US sex-abuse watchdog fires investigator after learning of his arrest for stealing drug money DENVER (AP) — The U.S. Center for SafeSport abruptly fired one of its investigators last month after learning he’d been arrested for stealing money confiscated after a drug bust he was part of during his previous job as a police officer. Jason Krasley left his job with the Allentown Police Department in Pennsylvania in 2021 and was hired by the Denver-based SafeSport center to look into sensitive cases involving sex abuse and harassment. The center said it conducts multiple interviews and a “comprehensive background check” of potential employees. The center said it was looking into cases Krasley handled to make sure they were dealt with appropriately. Jim Larrañaga steps down at Miami, Bill Courtney takes over to finish season CORAL GABLES, Fla. (AP) — Jim Larrañaga has stepped down as Miami’s men’s basketball coach effective immediately. Larrañaga will be replaced by associate head coach Bill Courtney — one of Larrañaga’s best friends for the past three decades or so — for the remainder of the season. The now-former coach says he loves the university but believes it's the right time to step away. Larrañaga says "I’ve tried every which way to keep this going.” Larrañaga joins a long line of prominent college basketball coaches who have left their jobs in recent years citing the changes in the game and the challenge of coaching in the Name, Image and Likeness era. Detroit Red Wings fire coach Derek Lalonde, name Todd McLellan as his replacement The Detroit Red Wings have fired coach Derek Lalonde and named Todd McLellan as his replacement. The move a day after Christmas comes after the Red Wings lost 21 of their first 34 games this season. They're on a three-game skid. Assistant Bob Boughner was also fired and Trent Yawney hired to work on McLellan's staff. McLellan signed a multiyear contract to start his fourth NHL head coaching job. Lalonde was nearly midway through his third season with Detroit after winning the Stanley Cup twice as an assistant with Tampa Bay. Pat Riley says the Miami Heat will not trade Jimmy Butler ORLANDO, Fla. (AP) — If Jimmy Butler wants a trade, the Miami Heat have no plans to make him happy. Heat President Pat Riley — in a rare move — spoke out to address rumors Thursday, saying the team has no plans to trade Butler. It’s a clear sign that, if necessary, the team will be willing to let Butler leave as a free agent and get nothing in return. Riley says in a release distributed by the team "we usually don’t comment on rumors, but all this speculation has become a distraction to the team and is not fair to the players and coaches.” Haaland penalty failure and Fernandes red card pile on woes for City and United in Premier League Erling Haaland’s failure from the penalty spot and Bruno Fernandes’ latest red card have compounded the woes of Manchester City and Manchester United on another tough day for the two Premier League giants. City dropped more points in its improbably poor run of form by drawing 1-1 at home to Everton. Haaland had a spot kick saved by England goalkeeper Jordan Pickford in the 53rd minute. The four-time defending champions have only won one of its last 13 games in all competitions. While City is languishing in seventh place, United is even further adrift in 14th place after a 2-0 loss at lowly Wolverhampton. Fernandes was sent off in the 47th. Simona Halep withdraws from Australian Open qualifying because of knee and shoulder pain MELBOURNE, Australia (AP) — Two-time Grand Slam champion Simona Halep has pulled out of Australian Open qualifying and a tuneup tournament in Auckland, New Zealand, because of pain in her knee and shoulder. Thursday's news represents the latest interruption of her comeback from a drug suspension. Halep posted on social media that she was feeling poorly after participating in an exhibition event in Abu Dhabi. The 33-year-old Romanian said she is planning to next enter the Transylvania Open in her home country, where play begins Feb. 3. Halep was granted a wild-card entry for qualifying in the Australian Open last week. Mahomes throws 3 TDs as Chiefs clinch AFC's top seed by breezing past the skidding Steelers 29-10 PITTSBURGH (AP) — Patrick Mahomes passed for 320 yards and three touchdowns and the Kansas City Chiefs locked up the top seed in the AFC for the fourth time in seven seasons with a 29-10 win over the Pittsburgh Steelers. The two-time defending Super Bowl champions raced to an early 13-point lead and were never really threatened by the Steelers (10-6). Pittsburgh has dropped three straight to see its chances of capturing the AFC North take another hit. Travis Kelce caught eight passes for 84 yards and a touchdown. Kelce also became the third tight end in NFL history to reach 1,000 receptions, joining Tony Gonzalez and Jason Witten. Jackson breaks Vick's NFL rushing record for QBs in Ravens' rout over Texans HOUSTON (AP) — Baltimore’s Lamar Jackson passed Michael Vick for the most yards rushing by a quarterback in NFL history in a 31-2 win over the Houston Texans in Wednesday. Jackson moved past Vick on a 6-yard run in the third quarter. Jackson had 87 yards rushing to give him 6,110 yards, moving him past Vick, who piled up 6,109 in his 13-year career. LeBron James scores 31 in record 19th Christmas Day game as Lakers hold off Curry, Warriors 115-113 SAN FRANCISCO (AP) — Austin Reaves scored the winning layup with one second left after Stephen Curry tied it on a 31-foot 3-pointer with seven seconds remaining, LeBron James had 31 points and 10 assists playing in his NBA-record 19th Christmas Day game, and the Los Angeles Lakers held off the Golden State Warriors 115-113. Curry scored 38 with eight 3s, hitting one under pressure from the baseline with 12 seconds left and another with 2:49 remaining only for James to answer from long range on the other end. Reaves recorded a triple-double. Bridges scores season-high 41, Knicks withstand Wembanyama's monster Christmas debut to edge Spurs NEW YORK (AP) — Mikal Bridges scored a season-high 41 points, and the New York Knicks overcame 42 from Victor Wembanyama in a monster Christmas debut to edge the San Antonio Spurs 117-114 on Wednesday. Wembanyama set a Spurs record for points on the holiday and added 18 rebounds, four assists and four blocked shots. The reigning Western Conference player of the week made six 3-pointers. But Bridges shot 17 for 25 from the field, 6 for 9 behind the arc, to make sure the Knicks had just enough offense to win their fifth in a row and improve to 20-10. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.🔬 The Debrief as Liverpool extend their lead; Chelsea stunned at home